{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:06:45Z","timestamp":1789913205854,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministerio de Ciencia, Innovaci\u00f3n y Universidades","award":["SAF2015-64945-R"],"award-info":[{"award-number":["SAF2015-64945-R"]}]},{"name":"Spanish Ministerio de Ciencia, Innovaci\u00f3n y Universidades","award":["SAF2016-78792-R"],"award-info":[{"award-number":["SAF2016-78792-R"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.neuropharm.2019.03.027","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T11:34:56Z","timestamp":1553340896000},"page":"134-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons"],"prefix":"10.1016","volume":"150","author":[{"given":"Andrea","family":"Ruiz-Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Bajo-Gra\u00f1eras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene B.","family":"Maroto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Zian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot F.","family":"Grabner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Garc\u00eda-Taboada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Resel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Zechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ortega-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Galve-Roperh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bellocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.03.027_bib1","doi-asserted-by":"crossref","first-page":"20564","DOI":"10.1073\/pnas.0706873104","article-title":"Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step","volume":"104","author":"Adermark","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s12035-018-1129-2","article-title":"The pharmacological inhibition of fatty acid amide hydrolase prevents excitotoxic damage in the rat striatum: possible involvement of CB1 receptors regulation","volume":"56","author":"Aguilera-Portillo","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib3","doi-asserted-by":"crossref","DOI":"10.4238\/gmr16029648","article-title":"Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review","volume":"16","author":"Apolinario","year":"2017","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcp.2018.08.016","article-title":"Cannabinoid pharmacology\/therapeutics in chronic degenerative disorders affecting the central nervous system","volume":"157","author":"Aymerich","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","article-title":"2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain","volume":"71","author":"Baggelaar","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/acschembio.6b01052","article-title":"Chemical proteomics maps brain region specific activity of endocannabinoid hydrolases","volume":"12","author":"Baggelaar","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib7","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/febs.12329","article-title":"In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system","volume":"280","author":"Bari","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib8","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1523\/JNEUROSCI.1192-16.2016","article-title":"Sustained Gq-protein signaling disrupts striatal circuits via JNK","volume":"36","author":"Bellocchio","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib9","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of disease phenotype in Huntington disease","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib10","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","volume":"22","author":"Blazquez","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib12","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","article-title":"Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease","volume":"32","author":"Bouchard","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib15","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nbd.2011.12.017","article-title":"Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease","volume":"45","author":"Chiodi","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib17","doi-asserted-by":"crossref","first-page":"e0191436","DOI":"10.1371\/journal.pone.0191436","article-title":"The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra","volume":"13","author":"Davis","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib19","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1476-5381.2011.01365.x","article-title":"Prospects for cannabinoid therapies in basal ganglia disorders","volume":"163","author":"Fernandez-Ruiz","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ordo\u00f1ez","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1755-5949.2010.00195.x","article-title":"The multiplicity of action of cannabinoids: implications for treating neurodegeneration","volume":"17","author":"Gowran","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1074\/jbc.M115.683615","article-title":"Deletion of monoglyceride lipase in astrocytes attenuates lipopolysaccharide-induced neuroinflammation","volume":"291","author":"Grabner","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","article-title":"Monoglyceride lipase as a drug target: at the crossroads of arachidonic acid metabolism and endocannabinoid signaling","volume":"175","author":"Grabner","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib26","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/glia.23314","article-title":"Localization of the cannabinoid type-1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus","volume":"66","author":"Gutierrez-Rodriguez","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cell.2012.01.037","article-title":"Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD","volume":"148","author":"Han","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib28","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1002\/anie.201407807","article-title":"A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis","volume":"53","author":"Hernandez-Torres","year":"2014","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse","volume":"61","author":"Hockly","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib30","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease","volume":"23","author":"Hsiao","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib32","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","article-title":"Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington's disease model mice","volume":"36","author":"Jiang","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.neuro.051508.135422","article-title":"Physiology and pharmacology of striatal neurons","volume":"32","author":"Kreitzer","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","article-title":"CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches","volume":"153B","author":"Langbehn","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib36","doi-asserted-by":"crossref","first-page":"35829","DOI":"10.1038\/srep35829","article-title":"Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuropharm.2010.01.008","article-title":"Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum","volume":"58","author":"Lovinger","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2006.11.006","article-title":"The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases","volume":"81","author":"Maccarrone","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1126\/science.aaa7945","article-title":"Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways","volume":"349","author":"Martin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib41","doi-asserted-by":"crossref","first-page":"13986","DOI":"10.1073\/pnas.0906463106","article-title":"Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin\/proteasome system impairment","volume":"106","author":"Maynard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib42","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib45","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/glia.23022","article-title":"Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease","volume":"64","author":"Meunier","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice","volume":"42","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-015-0012-0","article-title":"Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection","volume":"10","author":"More","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuron.2010.08.043","article-title":"Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes","volume":"68","author":"Navarrete","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuron.2014.06.030","article-title":"ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6\/2 mice","volume":"83","author":"Naydenov","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2014.08.009","article-title":"Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice","volume":"71","author":"Naydenov","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib52","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib53","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuropharm.2017.03.037","article-title":"Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS","volume":"124","author":"Pasquarelli","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuron.2018.04.034","article-title":"Astroglial CB1 receptors determine synaptic D-serine availability to enable recognition memory","volume":"98","author":"Robin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/cercor\/bhx285","article-title":"Pathway-specific control of striatal neuron vulnerability by corticostriatal cannabinoid CB1 receptors","volume":"28","author":"Ruiz-Calvo","year":"2018","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib58","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/glia.20838","article-title":"Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease","volume":"57","author":"Sagredo","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib59","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1476-5381.2011.01343.x","article-title":"Endocannabinoids and traumatic brain injury","volume":"163","author":"Shohami","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib62","doi-asserted-by":"crossref","first-page":"17467","DOI":"10.1074\/jbc.M110.215434","article-title":"Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance","volume":"286","author":"Taschler","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib64","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1523\/JNEUROSCI.0448-07.2007","article-title":"Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum","volume":"27","author":"Uchigashima","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib65","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1523\/JNEUROSCI.5665-10.2011","article-title":"Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus","volume":"31","author":"Uchigashima","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib66","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.celrep.2015.06.075","article-title":"Metabolic interplay between astrocytes and neurons regulates endocannabinoid action","volume":"12","author":"Viader","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib67","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2019.03.027_bib68","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1523\/JNEUROSCI.2419-04.2004","article-title":"ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase","volume":"24","author":"Walter","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.03.027_bib69","first-page":"487","article-title":"Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional huntington's disease mouse model","volume":"28","author":"Wood","year":"2019","journal-title":"Hum. Mol. Genet."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819301066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819301066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T20:54:28Z","timestamp":1656104068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819301066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":69,"alternative-id":["S0028390819301066"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.027","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}